Expression of p16 protein in patients with uterine smooth muscle tumors: an immunohistochemical analysis
Authors:
- Klaus BodnerKBKlaus Bodner
- Klaus CzerwenkaKCKlaus Czerwenka
- Oliver KimbergerOliver Kimberger
- Sepp LeodolterSLSepp Leodolter
- Klaus MayerhoferKMKlaus Mayerhofer
- 1 January 2005
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 96 (1) , 62-66
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Expression of p27, p21, and p16 protein in early squamous cervical cancer and its relation to prognosisGynecologic Oncology, 2003
- MIB-1 (Ki-67), p53, estrogen receptor, and progesterone receptor expression in uterine smooth muscle tumorsHuman Pathology, 2001
- p16(MTS-1/CDKN2/INK4a) in Cancer ProgressionExperimental Cell Research, 2001
- Frequent Occurrence of Loss of Heterozygosity among Tumor Suppressor Genes in Uterine LeiomyosarcomaGynecologic Oncology, 1999
- Underexpression of Cyclin-Dependent Kinase (CDK) Inhibitors in Cervical CarcinomaGynecologic Oncology, 1998
- Loss of RB and MTS1/CDKN2 (p16) expression in human sarcomasHuman Pathology, 1997
- Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinomaNature Genetics, 1994
- Problematic Uterine Smooth Muscle NeoplasmsAmerican Journal of Surgical Pathology, 1994
- A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor TypesScience, 1994
- Uterine fibroids: A clinical reviewBJOG: An International Journal of Obstetrics & Gynaecology, 1990